Inactive Instrument

Press Releases Smith & Nephew plc London S.E.

Equities

End-of-day quote London S.E. Other stock markets
- ^GBX	-

05-31	SMITH & NEPHEW : EPS cut (2023: +8.0%, 2024: -16.2%)
05-14	European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Smith & Nephew : NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM - Form 6-K	05-30	PU
Smith & Nephew : Director/Pdmr Shareholding - Form 6-K	05-24	PU
4 Stocks to Watch in the Booming Regenerative Medicine Market	05-20	AQ
Smith & Nephew : STERLING AMOUNT OF DIVIDEND - Form 6-K	05-09	PU
Smith & Nephew : Directorate Change - Form 6-K	05-08	PU
Smith+Nephew Announces new evidence supporting ALLEVYN LIFE Foam Dressing's role in pressure injury prevention	04-22	AQ
Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention	04-18	GL
Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)	04-04	GL
Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds	04-01	GL
Smith & Nephew : Directorate Change - Form 6-K	03-28	PU
Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner	03-25	GL
Smith & Nephew : Notice of Annual General Meeting	03-11	PU
Smith+Nephew and U.S. Army Institute of Surgical Research to engage in Master Cooperative Research and Development Agreement	02-28	GL
Smith & Nephew : +Nephew Fourth Quarter and Full Year 2023 Results	02-26	PU
Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting	02-13	GL
Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting	02-12	GL
Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting	02-12	GL
New study confirms Smith+Nephew's REGENETEN Bioinductive Implant reduces full-thickness rotator cuff re-tear rates-1 by 68%	01-12	AQ
New study confirms Smith+Nephew’s REGENETEN™ Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68%	01-11	GL
HippoFi Hires World's Top Regenerative Therapy Expert, Dr. Gail Naughton, to Drive Commercialization Plans of its Proprietary Technologies	12-12	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SMITH & NEPHEW : EPS cut (2023: +8.0%, 2024: -16.2%)

May 31, 2024 at 02:56 am